The immunogenicity of influenza vaccination in elderly institutionalized patients, with a variety of clinical disorders, was tested in an open multicenter study involving 495 people (mean age 80 years). Vaccination with an inactivated split influenza vaccine (FluarixTM) was clinically well tolerated. For all age ranges and all strains of virus, the vaccine elicited a humoral response which surpassed the European Community requirements for influenza vaccines in adults over 60 years. The geometric mean titers for all vaccine strains were significantly increased 28 days after vaccination, and remained higher than prevaccination levels after 6 months. These immunological parameters were unaffected by the clinical status of the patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.